10 Reduced Inequalities

New views to restoring spinal function

A state-of-the-art livecyte microscope at the Griffith Institute for Drug Discovery is leading the Spinal Injury Project team toward human clinical trials.
Published
3 Good Health and Well Being

Smell Clinic commences as researchers gather more data on Alzheimer’s disease

A pilot smell clinic has commenced at Griffith’s Gold Coast campus in a bid to gather more data on how microorganisms within the nose can contribute to Alzheimer’s disease.
Published
3 Good Health and Well Being

Call for more research into what causes Alzheimer’s

Calls for more study to be conducted into how microorganisms contribute to the onset and progression of Alzheimer’s disease.
Published
10 Reduced Inequalities

Funding boost for world-first cell transplantation research for nervous system repair

Griffith University’s world-first study into cell transplantation to repair injuries to the nervous system has received a major boost thanks to a $5.4 million funding extension from the MAIC.
Published
Biospine

Vale: Griffith farewells Alan Mackay-Sim, a titan of science

Griffith University is paying tribute to one of its finest in Professor Emeritus Alan Mackay-Sim AM known to many as a pioneering stem-cell research scientist and former recipient of the Australian of the Year award. Professor Mackay-Sim passed away early in the new year at the age of 71. In 1987, Professor Mackay-Sim came to […]
Published
Clem Jones Centre for Neurobiology and Stem Cell Research

Griffith joins $280 million partnership to deliver mRNA vaccine outcomes

Queensland will become a global mRNA vaccine hub with global healthcare company Sanofi partnering with Griffith University and other leading research institutions to establish a world-first research centre in south east Queensland.
Published
Clem Jones Centre for Neurobiology and Stem Cell Research

Griffith team start spinal cord injury rehabilitation trial

Griffith University is seeking five people living with spinal cord injury to be part of stage two of an innovative trial which will test intensive rehabilitation for those living with chronic spinal cord paralysis.
Published